# Sanket Agrawal

> Sanket Agrawal is a Los Angeles-based executive and fractional CEO associated with General Inception. His career spans consulting, software, twelve years at Amgen, business leadership at Foundation Medicine and the CEO role at 1859, which he joined in April 2023. His public advice to founders emphasizes execution and human relationships.

- **Role:** Fractional CEO at General Inception
- **Organizations:** General Inception, 1859, Foundation Medicine, Amgen, Relsys International, SAVtech Solutions, Deloitte Consulting, Accenture, Arima Genomics
- **Education:** Bachelor of Engineering, Delhi College of Engineering, Master of Engineering, Information Systems, University of Toronto, MBA, UCLA Anderson School of Management
- **Known for:** Appointed CEO of 1859 effective April 2023., Appointed Chief BioPharma Business Officer at Foundation Medicine in 2021 with responsibility for expanding partnerships., Held leadership roles during a twelve-year Amgen tenure.

## Career timeline

- **1995–1997** — Analyst at Accenture in the Toronto area.
- **1997–1999** — Manager at Deloitte Consulting in Toronto.
- **1999–2003** — Co-founder and principal of SAVtech Solutions.
- **2003–2008** — Strategy and business leadership at Relsys International.
- **2009–2021** — Held strategy, operations, commercial and general-management roles at Amgen.
- **2021–2023** — Chief BioPharma Business Officer at Foundation Medicine; appointment announced August 2021.
- **2023–2024** — CEO of 1859; joined in April 2023.
- **2024–present** — Fractional CEO at General Inception, as listed in supplied information and public professional-profile data.
- **2024–2025** — Advisor at Arima Genomics, according to public professional-profile data.
- **2025–present** — Business advisor to an unnamed stealth company, according to public professional-profile data.

## Achievements

- Appointed CEO of 1859 effective April 2023.
- Appointed Chief BioPharma Business Officer at Foundation Medicine in 2021 with responsibility for expanding partnerships.
- Held leadership roles during a twelve-year Amgen tenure.
- Spoke on a September 6, 2023 EvoNexus and Wilson Sonsini business development and fundraising panel.
- Co-founded SAVtech Solutions, according to public professional-profile data.

## Latest updates

- **2023-09** — Participated in the September 6 EvoNexus and Wilson Sonsini fundraising panel in San Diego.
- **2023-06** — 1859 publicly announced his CEO appointment, effective April 2023.

## Links

- Website: https://www.generalinception.com/team
- LinkedIn: https://www.linkedin.com/in/sanketagrawal

---

Profile page: https://yespress.io/sanket-agrawal
Published by YesPress — https://yespress.io
Last updated: 2026-10-09